HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. increased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 28.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,256 shares of the company's stock after buying an additional 946 shares during the period. Atria Wealth Solutions Inc.'s holdings in HCA Healthcare were worth $1,277,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in HCA. Integrated Advisors Network LLC boosted its holdings in shares of HCA Healthcare by 0.6% during the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company's stock worth $2,086,000 after purchasing an additional 31 shares during the period. First Horizon Advisors Inc. grew its stake in shares of HCA Healthcare by 2.4% in the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company's stock worth $623,000 after acquiring an additional 36 shares during the last quarter. Mediolanum International Funds Ltd lifted its position in HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock valued at $3,153,000 after acquiring an additional 36 shares in the last quarter. Hartford Funds Management Co LLC boosted its holdings in shares of HCA Healthcare by 1.6% during the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company's stock valued at $1,003,000 after acquiring an additional 39 shares during the last quarter. Finally, Prairie Wealth Advisors Inc. raised its stake in HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on HCA. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. KeyCorp cut their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Royal Bank of Canada lowered their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Morgan Stanley dropped their target price on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded up $0.64 during trading on Thursday, hitting $320.55. 1,788,584 shares of the company's stock were exchanged, compared to its average volume of 1,694,602. The stock has a market capitalization of $79.60 billion, a price-to-earnings ratio of 14.59, a PEG ratio of 1.10 and a beta of 1.64. The business has a 50-day simple moving average of $314.65 and a 200-day simple moving average of $350.12. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the business posted $5.90 earnings per share. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. The ex-dividend date is Monday, March 17th. HCA Healthcare's dividend payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.